ATE266675T1 - Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese - Google Patents

Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese

Info

Publication number
ATE266675T1
ATE266675T1 AT97905992T AT97905992T ATE266675T1 AT E266675 T1 ATE266675 T1 AT E266675T1 AT 97905992 T AT97905992 T AT 97905992T AT 97905992 T AT97905992 T AT 97905992T AT E266675 T1 ATE266675 T1 AT E266675T1
Authority
AT
Austria
Prior art keywords
fragments
angiogenesis
inhibitors
troponin subunits
troponin
Prior art date
Application number
AT97905992T
Other languages
English (en)
Inventor
Marsha A Moses
Robert S Langer
Dimitri G Wiederschain
Inmin Wu
Arthur Sytkowski
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Application granted granted Critical
Publication of ATE266675T1 publication Critical patent/ATE266675T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT97905992T 1996-02-16 1997-02-14 Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese ATE266675T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/602,941 US5837680A (en) 1996-02-16 1996-02-16 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
PCT/US1997/002439 WO1997030085A1 (en) 1996-02-16 1997-02-14 Troponin subunits and fragments useful as angiogenesis inhibitors

Publications (1)

Publication Number Publication Date
ATE266675T1 true ATE266675T1 (de) 2004-05-15

Family

ID=24413387

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97905992T ATE266675T1 (de) 1996-02-16 1997-02-14 Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese

Country Status (8)

Country Link
US (4) US5837680A (de)
EP (1) EP1007556B1 (de)
JP (1) JP3990456B2 (de)
AT (1) ATE266675T1 (de)
AU (1) AU707262B2 (de)
CA (1) CA2247247C (de)
DE (1) DE69729125T2 (de)
WO (1) WO1997030085A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586401B1 (en) * 1996-02-16 2003-07-01 Children's Medical Center Corporation Troponin subunit I fragment and homologs thereof
US6465431B1 (en) * 1999-11-17 2002-10-15 Boston Life Sciences, Inc. Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
US6589936B1 (en) 1996-02-16 2003-07-08 Children's Medical Center Corporation Pharmaceutical compositions comprising recombinant troponin subunits
US5837680A (en) 1996-02-16 1998-11-17 Children's Medical Center Corporation Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
US20030166065A1 (en) * 1997-04-24 2003-09-04 Human Genome Sciences, Inc. Novel integrin ligand ITGL-TSP
US7220557B2 (en) * 1997-04-24 2007-05-22 Human Genome Sciences, Inc. METH1 polynucleotides
US6248869B1 (en) * 1997-05-29 2001-06-19 Medical Analysis Systems, Inc. Troponin I forms and use of the same
US6468519B1 (en) * 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
WO1999016889A1 (en) * 1997-10-01 1999-04-08 G.D. Searle & Co. Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment
KR100335397B1 (ko) * 1998-05-25 2002-09-05 주식회사 하이닉스반도체 센스앰프순차구동장치
WO2000004145A2 (en) * 1998-07-17 2000-01-27 Carpen Olli Myotilin, an actin-organizing protein
US6378526B1 (en) * 1998-08-03 2002-04-30 Insite Vision, Incorporated Methods of ophthalmic administration
WO2000023585A1 (en) * 1998-10-21 2000-04-27 Spectral Diagnostics, Inc. Cardiac troponin i polypeptide fragments and uses in diagnostics
WO2000054770A1 (en) * 1999-03-15 2000-09-21 Boston Life Sciences, Inc. Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
JP2003500041A (ja) * 1999-05-25 2003-01-07 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド Meth1およびmeth2ポリヌクレオチドおよびポリペプチド
US20020142982A1 (en) * 1999-09-02 2002-10-03 Timothy Hla Method for regulating angiogenesis
DE60138465D1 (de) 2000-07-12 2009-06-04 Agensys Inc Neues tumor antigen das für diagnose und therapie von blasen-, eierstock-, lungen- und nierenkrebs verwendet werden kann
US20030236188A1 (en) * 2001-05-03 2003-12-25 Spytek Kimberly A. Novel human proteins, polynucleotides encoding them and methods of using the same
WO2003066854A1 (fr) * 2002-02-04 2003-08-14 Yoshida, Hideo Agent anticancereux utilisant des variantes de verotoxines
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
WO2004065621A1 (en) 2002-03-01 2004-08-05 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
SI2301587T1 (sl) 2002-03-01 2014-11-28 Dyax Corp. KDR in VEGF/KDR vezavni peptidi in njihova uporaba pri diagnozi
US7211240B2 (en) * 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
WO2003080116A1 (en) * 2002-03-21 2003-10-02 University Of Florida Modulating angiogenesis
US20060189519A1 (en) * 2002-09-26 2006-08-24 Karl Volz Anti-angiogenic fragments fo pigment epithelium-derived factor (pedf)
ES2557286T3 (es) 2003-03-03 2016-01-25 Dyax Corp. Usos de péptidos que se unen específicamente al receptor del HGF (cMet)
CN1294987C (zh) * 2003-04-15 2007-01-17 刘凤鸣 心肌肌钙蛋白i在制备抑制肿瘤药物中的应用
US7530968B2 (en) 2003-04-23 2009-05-12 Valeritas, Inc. Hydraulically actuated pump for long duration medicament administration
US9089636B2 (en) 2004-07-02 2015-07-28 Valeritas, Inc. Methods and devices for delivering GLP-1 and uses thereof
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
US7265248B1 (en) 2005-04-29 2007-09-04 Technology Innovations, Llc Compositions and methods for the treatment of malaria
US20070130009A1 (en) * 2005-06-01 2007-06-07 Chad Steelberg System and method for media play pricing
WO2007067611A2 (en) * 2005-12-07 2007-06-14 The Brigham And Women's Hospital, Inc. Methods of treating cardiac reperfusion disease
CN103239773B (zh) 2006-03-30 2015-08-26 瓦莱里塔斯公司 多筒式流体递送器械
US8468561B2 (en) 2006-08-09 2013-06-18 Google Inc. Preemptible station inventory

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0512071T3 (da) * 1990-01-25 1996-11-25 Childrens Hospital Fremgangsmåde og sammensætninger til inhibering af angiogenese
FR2701954B1 (fr) * 1993-02-23 1995-07-07 Pasteur Sanofi Diagnostics Composition stabilisée de troponine pour immunoessais et procédé de stabilisation de troponine pour immunoessais.
US5837680A (en) 1996-02-16 1998-11-17 Children's Medical Center Corporation Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis

Also Published As

Publication number Publication date
EP1007556A4 (de) 2000-06-14
WO1997030085A1 (en) 1997-08-21
JP3990456B2 (ja) 2007-10-10
AU2275397A (en) 1997-09-02
US6403558B1 (en) 2002-06-11
DE69729125T2 (de) 2005-05-12
EP1007556B1 (de) 2004-05-12
CA2247247A1 (en) 1997-08-21
AU707262B2 (en) 1999-07-08
US6653283B1 (en) 2003-11-25
EP1007556A2 (de) 2000-06-14
US6025331A (en) 2000-02-15
CA2247247C (en) 2010-08-03
JP2000506523A (ja) 2000-05-30
US5837680A (en) 1998-11-17
DE69729125D1 (de) 2004-06-17

Similar Documents

Publication Publication Date Title
DE69729125D1 (de) Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
EA200401471A1 (ru) Применение ингибиторов сетр и возможных ингибиторов hmg coa и/или антигипертензивных агентов
FI961976A0 (fi) Peptidyyliyhdisteitä ja niiden terapeuttinen käyttö metalloproteinaasien inhibiittoreina
ID23877A (id) Senyawa-senyawa dan metode-metode untuk penghambatan ekspresi vcam-1
DE69837809D1 (de) Apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dislipidemischer erkrankungen
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
YU7797A (sh) Kombinovana terapija za osteoporozu
BR9917038A (pt) Composto, composição farmacêutica, método de modulação da atividade receptora de quimocinas, método de tratamento ou prevenção de doenças inflamatórias, método de tratamento ou prevenção de asma e método de tratamento ou prevenção de disfunções inflamatórias
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
ATE221885T1 (de) Substituierte sulfonylphenylheterocyclen als cyclooxygenase-2 und 5- lipoxygenase inhibitoren
DE69839815D1 (de) Verwendung von ppar-gamma aktivatoren zur behandlung von hautkrankheiten
BR9712085A (pt) Inibidores de metaloprotease heterocìclicos
DE60112766D1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
DE60313004D1 (de) Alpha-7-nikotinsäure-rezeptoragonisten und statine in kombination
EA200500782A1 (ru) Лечение геморрагического шока
EA200500849A1 (ru) Новые соединения лапахона и способы их применения
DE60008753D1 (de) Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen
ATE271861T1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
DE60329326D1 (de) Tace inhibitoren
ATE313561T1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
TR200200278T2 (tr) Kalsilitik bileşimler

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties